Employee Benefit Plans (Tables)

12 Months Ended

Dec. 31, 2023

Employee Benefit and Share-Based Payment Arrangement, Noncash Expense [Abstract]

Schedule of Stock Option Activity

Stock option activity was as follows:

(In thousands, except per share amounts)	Number of Shares			Weighted Average Exercise Price Per Share		Weighted Average Remaining Contractual Term		Aggregate Intrinsic Value
Outstanding as of December 31, 2022		872		$	30.64
Expired		(6	)	$	21.79
Outstanding as of December 31, 2023		866		$	30.70		4.05	$	—
As of December 31, 2023
Vested and expected to vest		866		$	30.70		4.05	$	—
Exercisable Options		866		$	30.70		4.05	$	—

Schedule of Ranges of Outstanding And Exercisable Stock Options

The following table summarizes significant ranges of outstanding and exercisable stock options as of December 31, 2023:

	Options Outstanding						Options Exercisable
Range of Exercise Prices	Shares Outstanding		Weighted- Average Remaining Contractual Life		Weighted- Average Exercise Price Per Share		Shares Exercisable		Weighted- Average Exercise Price Per Share
	(In thousands)		(In years)		(In dollars)		(In thousands)		(In dollars)
$18.58 - $18.58		17		1.42	$	18.58		17	$	18.58
$19.32 - $19.32		17		0.42	$	19.32		17	$	19.32
$19.99 - $19.99		2		0.31	$	19.99		2	$	19.99
$23.48 - $23.48		31		2.23	$	23.48		31	$	23.48
$25.37 - $25.37		152		3.11	$	25.37		152	$	25.37
$26.61 - $26.61		369		5.06	$	26.61		369	$	26.61
$38.32 - $38.32		25		4.59	$	38.32		25	$	38.32
$41.67 - $41.67		253		3.74	$	41.67		253	$	41.67
$18.58 - $41.67		866		4.05	$	30.70		866	$	30.70

Schedule of RSU Activity

RSU activity was as follows:

(In thousands, except per share amounts)	Number of Shares			Weighted Average Grant Date Fair Value Per Share		Weighted Average Remaining Contractual Term		Average Intrinsic Value
Outstanding as of December 31, 2022		1,546		$	27.82
Granted		773		$	17.32
Vested		(649	)	$	27.36
Cancelled		(103	)	$	24.72
Outstanding as of December 31, 2023		1,567		$	22.83		1.35	$	22,844

Schedule of Performance Shares Activity

Performance shares activity was as follows:

(In thousands, except per share amounts)	Number of Shares			Weighted Average Grant Date Fair Value Per Share
Outstanding as of December 31, 2020		141		$	28.22
Granted		152		$	37.58
Vested		—			—
Cancelled		—			—
Outstanding as of December 31, 2021		293		$	33.07
Granted		145		$	22.37
Vested		—			—
Cancelled		(8	)	$	27.17
Outstanding as of December 31, 2022		430		$	29.38
Granted		145		$	14.44
Vested		—			—
Cancelled		(158	)	$	27.85
Outstanding as of December 31, 2023		417		$	24.76

Schedule of Weighted Average Assumptions

The following table sets forth the weighted-average assumptions used to estimate the fair value of purchase rights granted under the ESPP:

	Year Ended December 31,
	2023			2022			2021
Expected life (in years)		0.5			0.5			0.5
Risk-free interest rate		5.19	%		2.25	%		0.05	%
Expected volatility		35.8	%		39.6	%		40.8	%
Dividend yield		—			—			—

Schedule of Total Stock-Based Compensation Expense Resulting from Stock Options, RSUs, Performance Shares and the ESPP

The following table sets forth the stock-based compensation expense resulting from stock options, RSUs, performance shares and the ESPP included in the Company’s consolidated statements of operations:

	Year Ended December 31,
(In thousands)	2023		2022		2021
Cost of revenue	$	1,405	$	1,353	$	2,103
Research and development		3,935		4,177		5,161
Sales and marketing		5,336		5,603		7,628
General and administrative		7,262		6,601		11,103
Total	$	17,938	$	17,734	$	25,995